Durect Corporation Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 50.74. In total, the insiders bought 7 113 787 764 and sold 373 772 DRRX shares in the last 100 trades.

Insider Power

(Last 100 transactions)
50.74
Buy 7 113 788 Shares
Sell 373 772 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 21, 2023 Stock Option (right to buy) Buy Robertson Judith J. 5 500
Jun 21, 2023 Stock Option (right to buy) Buy Maderis Gail J 5 500
Jun 21, 2023 Stock Option (right to buy) Buy Garcia Peter S 5 500
Jun 21, 2023 Stock Option (right to buy) Buy Farfel Gail M 5 500
Jun 21, 2023 Stock Option (right to buy) Buy Blaschke Terrence F 5 500
Jun 21, 2023 Stock Option (right to buy) Buy Azab Mohammad 5 500
Mar 13, 2023 Common Stock Sell Bleichroeder Lp 3 498
Feb 21, 2023 Stock Option (right to buy) Buy Sussman Norman 45 000
Feb 21, 2023 Stock Option (right to buy) Buy Sussman Norman 24 557
Feb 21, 2023 Stock Option (right to buy) Buy Papp Timothy M. 60 000
Feb 21, 2023 Stock Option (right to buy) Buy Papp Timothy M. 12 377
Feb 21, 2023 Stock Option (right to buy) Buy Joice Judy R 20 000
Feb 21, 2023 Stock Option (right to buy) Buy Joice Judy R 17 456
Feb 21, 2023 Stock Option (right to buy) Buy Brown James E 200 000
Feb 21, 2023 Stock Option (right to buy) Buy Brown James E 50 665
Aug 18, 2022 Common Stock Buy Robertson Judith J. 9 412
Aug 17, 2022 Common Stock Buy Robertson Judith J. 8 130
Aug 12, 2022 Common Stock Buy Maderis Gail J 25 204
Aug 11, 2022 Common Stock Buy Maderis Gail J 24 796
Aug 09, 2022 Common Stock Buy Maderis Gail J 79 693
Aug 09, 2022 Common Stock Buy Maderis Gail J 70 307
Jul 01, 2022 Stock Option (right to buy) Buy Papp Timothy M. 600 000
Jul 01, 2022 Buy Papp Timothy M. 0
Jun 15, 2022 Stock Option (right to buy) Buy Robertson Judith J. 55 000
Jun 15, 2022 Stock Option (right to buy) Buy Maderis Gail J 55 000
Click to get the best stock tips daily for free!

About Durect Corporation

Durect DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in... DRRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT